Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
273 | 3 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//DRUG METABOLISM AND DISPOSITION | 43782 |
444 | 2 | CYTOCHROME P450//EPOXYEICOSATRIENOIC ACIDS//CYP2D6 | 16462 |
1473 | 1 | CYP2D6//DEBRISOQUINE//CYP2C19 | 2652 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CYP2D6 | authKW | 2409708 | 18% | 43% | 476 |
2 | DEBRISOQUINE | authKW | 987042 | 4% | 74% | 112 |
3 | CYP2C19 | authKW | 612774 | 7% | 26% | 195 |
4 | POOR METABOLIZER | authKW | 347881 | 2% | 60% | 49 |
5 | CYP2D6 POLYMORPHISM | authKW | 307970 | 1% | 72% | 36 |
6 | PHARMACOGENETICS | journal | 301829 | 6% | 16% | 155 |
7 | MEPHENYTOIN | authKW | 301216 | 1% | 69% | 37 |
8 | ULTRARAPID METABOLIZER | authKW | 183322 | 1% | 86% | 18 |
9 | CYTOCHROME P450 2D6 | authKW | 175707 | 2% | 34% | 43 |
10 | CICAB CLIN | address | 142836 | 1% | 52% | 23 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 35287 | 66% | 0% | 1751 |
2 | Medical Laboratory Technology | 2520 | 5% | 0% | 141 |
3 | Toxicology | 1637 | 8% | 0% | 215 |
4 | Psychiatry | 643 | 7% | 0% | 177 |
5 | Genetics & Heredity | 350 | 6% | 0% | 164 |
6 | Medicine, Legal | 161 | 1% | 0% | 25 |
7 | Clinical Neurology | 90 | 4% | 0% | 111 |
8 | Medicine, Research & Experimental | 45 | 3% | 0% | 75 |
9 | Chemistry, Analytical | 39 | 3% | 0% | 87 |
10 | Biochemical Research Methods | 37 | 2% | 0% | 60 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CICAB CLIN | 142836 | 1% | 52% | 23 |
2 | SECT DEV PHARMACOL EXPT THER EUT | 72764 | 1% | 44% | 14 |
3 | CLIN PHARMACOL TOXICOL THER EUT INNOVAT | 44606 | 0% | 29% | 13 |
4 | CICAB | 27716 | 0% | 33% | 7 |
5 | CLIN PHARMACOL | 27566 | 9% | 1% | 245 |
6 | DEV PHARMACOL EXPT THER EUT | 26734 | 0% | 75% | 3 |
7 | PHARMACOGENET CORE | 26734 | 0% | 75% | 3 |
8 | CLIN PHARMACOL TOXICOL INNOVAT THER EUT | 23765 | 0% | 100% | 2 |
9 | S HLTH CHEM | 23765 | 0% | 100% | 2 |
10 | NUCLEOTIDE POLYMORPHISM | 21386 | 0% | 60% | 3 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | PHARMACOGENETICS | 301829 | 6% | 16% | 155 |
2 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 77832 | 7% | 3% | 197 |
3 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 49023 | 6% | 2% | 172 |
4 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 42575 | 6% | 2% | 172 |
5 | PHARMACOGENOMICS | 26458 | 2% | 3% | 64 |
6 | DRUG METABOLISM AND DISPOSITION | 14000 | 4% | 1% | 95 |
7 | THERAPEUTIC DRUG MONITORING | 13157 | 2% | 2% | 65 |
8 | PHARMACOGENOMICS JOURNAL | 11010 | 1% | 3% | 28 |
9 | XENOBIOTICA | 6289 | 2% | 1% | 46 |
10 | PHARMACOGENETICS AND GENOMICS | 5355 | 1% | 2% | 23 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CYP2D6 | 2409708 | 18% | 43% | 476 | Search CYP2D6 | Search CYP2D6 |
2 | DEBRISOQUINE | 987042 | 4% | 74% | 112 | Search DEBRISOQUINE | Search DEBRISOQUINE |
3 | CYP2C19 | 612774 | 7% | 26% | 195 | Search CYP2C19 | Search CYP2C19 |
4 | POOR METABOLIZER | 347881 | 2% | 60% | 49 | Search POOR+METABOLIZER | Search POOR+METABOLIZER |
5 | CYP2D6 POLYMORPHISM | 307970 | 1% | 72% | 36 | Search CYP2D6+POLYMORPHISM | Search CYP2D6+POLYMORPHISM |
6 | MEPHENYTOIN | 301216 | 1% | 69% | 37 | Search MEPHENYTOIN | Search MEPHENYTOIN |
7 | PHARMACOGENETICS | 191803 | 10% | 6% | 266 | Search PHARMACOGENETICS | Search PHARMACOGENETICS |
8 | ULTRARAPID METABOLIZER | 183322 | 1% | 86% | 18 | Search ULTRARAPID+METABOLIZER | Search ULTRARAPID+METABOLIZER |
9 | CYTOCHROME P450 2D6 | 175707 | 2% | 34% | 43 | Search CYTOCHROME+P450+2D6 | Search CYTOCHROME+P450+2D6 |
10 | CYP2D610 | 124175 | 1% | 58% | 18 | Search CYP2D610 | Search CYP2D610 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |